Dr. Gene J. Lin, MD

Dr. Lin practices at Peninsula Physical Therapy - Rolling Hills Estates in Rolling Hills Estates, California.

Dr. Lin's NPI, 1932299252, was assigned on October 15, 2006. Dr. Lin graduated from University of California, Geffen School of Medicine in 1989. Dr. Lin holds California license G69919.

Dr. Lin's primary practice is Peninsula Physical Therapy - Rolling Hills Estates, at 550 Deep Valley Dr, Rolling Hills Estates, CA 90274. The practice phone is (310) 544-6264.

Dr. Lin's primary practice is Peninsula Physical Therapy - Rolling Hills Estates in Rolling Hills Estates, California. The medical group on file is Pacific Dermatology Specialists. Dmand AI also links Dr. Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lin is licensed in California.

CMS data shows 2,141 Medicare services from Dr. Lin across 20 procedure codes in 2024, for 282 Medicare patients. Medicare paid $223,398 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 77, with 53% women.

In 2024, Dr. Lin wrote 242 Medicare Part D claims for 117 patients. 98% of them were for generic drugs. CMS names the drug for 171 of them, across 8 drugs with 11 or more claims each, at $5,090 in total drug cost. In 2023, CMS named 129 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 53 procedures of melanoma (skin cancer) excision by Dr. Lin, more than 87% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Lin, published from 2013 to 2018. 2013 was the busiest year, with 2. The most frequent topics are Receptor, Adenosine A2A, Adenosine A2 Receptor Agonists and Anemia, Sickle Cell. Dr. Lin's most frequent co-authors are Joshua J. Field, MD, Elaine M. Majerus, MD and Jeffrey Keefer, MD.

CMS Open Payments shows 28 general payments to Dr. Lin from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $254.

Dr. Lin graduated from University of California, Geffen School of Medicine in 1989.